USCB(USCB)
USCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $113M | $124M |
| Low | $112M | $123M |
| High | $114M | $125M |
| EBITDA Avg | $34M | $37M |
| Low | $33M | $37M |
| High | $34M | $37M |
| EBIT Avg | $33M | $36M |
| Low | $33M | $36M |
| High | $33M | $36M |
| Net Income Avg | $38M | $43M |
| Low | $38M | $41M |
| High | $39M | $44M |
| EPS Avg | $2.09 | $2.33 |
| Low | $2.05 | $2.25 |
| High | $2.12 | $2.42 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $29M | $30M | $30M | $31M | $32M | $32M |
| Low | $29M | $29M | $29M | $30M | $31M | $32M |
| High | $30M | $30M | $30M | $31M | $32M | $33M |
| EBITDA Avg | $9M | $9M | $9M | $9M | $9M | $10M |
| Low | $9M | $9M | $9M | $9M | $9M | $9M |
| High | $9M | $9M | $9M | $9M | $10M | $10M |
| EBIT Avg | $8M | $9M | $9M | $9M | $9M | $9M |
| Low | $8M | $9M | $8M | $9M | $9M | $9M |
| High | $9M | $9M | $9M | $9M | $9M | $9M |
| Net Income Avg | $10M | $10M | $10M | $11M | $11M | $11M |
| Low | $10M | $10M | $10M | $10M | $11M | $11M |
| High | $11M | $11M | $10M | $11M | $11M | $11M |
| EPS Avg | $0.56 | $0.56 | $0.55 | $0.57 | $0.60 | $0.61 |
| Low | $0.53 | $0.55 | $0.53 | $0.56 | $0.59 | $0.59 |
| High | $0.59 | $0.58 | $0.56 | $0.58 | $0.61 | $0.62 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |